Sophoricoside isolated from Sophora japonica ameliorates contact dermatitis by inhibiting NF-κB signaling in B cells

Cited 31 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorH K Lee-
dc.contributor.authorH S Kim-
dc.contributor.authorY J Kim-
dc.contributor.authorJ S Kim-
dc.contributor.authorY S Park-
dc.contributor.authorJong Soon Kang-
dc.contributor.authorD Y Yuk-
dc.contributor.authorJ T Hong-
dc.contributor.authorY Kim-
dc.contributor.authorS B Han-
dc.date.accessioned2017-04-19T09:37:23Z-
dc.date.available2017-04-19T09:37:23Z-
dc.date.issued2013-
dc.identifier.issn1567-5769-
dc.identifier.uri10.1016/j.intimp.2013.01.025ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/11243-
dc.description.abstractSophoricoside (SOPH) is an isoflavone isolated from . Sophora japonica (Leguminosae). In this study, the inhibitory effect of SOPH on contact dermatitis was investigated. At dosages of 3 and 10. mg/kg, SOPH ameliorated 2,4-dinitrochlorobenzene-induced acute and chronic contact dermatitis by 50-70%. As cellular targets, SOPH mainly affected the functions of B cells rather than T cells, macrophages and dendritic cells. As signaling targets, SOPH inhibited the phosphorylation and degradation of IκBα/β and the nuclear translocation of NF-κB p65 in B cells, but not in dendritic cells and macrophages. SOPH did not affect the phosphorylation of ERK, p38, and JNK MAPKs, in B cells, dendritic cells, and macrophages. Taken together, these results suggest that SOPH ameliorates contact dermatitis by inhibiting mainly NF-κB signaling in B cells.-
dc.publisherElsevier-
dc.titleSophoricoside isolated from Sophora japonica ameliorates contact dermatitis by inhibiting NF-κB signaling in B cells-
dc.title.alternativeSophoricoside isolated from Sophora japonica ameliorates contact dermatitis by inhibiting NF-κB signaling in B cells-
dc.typeArticle-
dc.citation.titleInternational Immunopharmacology-
dc.citation.number3-
dc.citation.endPage473-
dc.citation.startPage467-
dc.citation.volume15-
dc.contributor.affiliatedAuthorJong Soon Kang-
dc.contributor.alternativeName이홍경-
dc.contributor.alternativeName김형숙-
dc.contributor.alternativeName김연진-
dc.contributor.alternativeName김지성-
dc.contributor.alternativeName박윤수-
dc.contributor.alternativeName강종순-
dc.contributor.alternativeName육동연-
dc.contributor.alternativeName홍진태-
dc.contributor.alternativeName김영수-
dc.contributor.alternativeName한상배-
dc.identifier.bibliographicCitationInternational Immunopharmacology, vol. 15, no. 3, pp. 467-473-
dc.identifier.doi10.1016/j.intimp.2013.01.025-
dc.subject.keywordB cells-
dc.subject.keywordContact dermatitis-
dc.subject.keywordNF-κB-
dc.subject.keywordSophoricoside-
dc.subject.localB cell-
dc.subject.localB cells-
dc.subject.localContact dermatitis-
dc.subject.localNuclear factor-kappa B-
dc.subject.localnuclear factor κB-
dc.subject.localNf-κb-
dc.subject.localNF-kB-
dc.subject.localnuclear factor kappa B-
dc.subject.localNF-κB (nuclear factor kappa-B)-
dc.subject.localNF-kappaB-
dc.subject.localNuclear factor-κb-
dc.subject.localNF-κ B-
dc.subject.localNF-κB-
dc.subject.localNF-kappa B-
dc.subject.localNuclear factor κB (NF-κB)-
dc.subject.localNuclear factor κB-
dc.subject.localNFκB-
dc.subject.localNf-κB-
dc.subject.localNuclear factor-κB-
dc.subject.localnuclear factorκB-
dc.subject.localNuclear factor (NF)-κB-
dc.subject.localNuclear factor kappa B-
dc.subject.localnuclear factor-κB-
dc.subject.localNF-ΚB-
dc.subject.localNuclear factor-kappa B (NF-κB)-
dc.subject.localNuclear factor-kappaB-
dc.subject.localnuclear factor-kappaB-
dc.subject.localnuclear factor-kappaB (NF-κB)-
dc.subject.localNFkappaB-
dc.subject.localNuclear factor kappaB-
dc.subject.localsophoricoside-
dc.subject.localSophoricoside-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.